In diffuse large B-cell lymphoma (DLBCL), the KIAA1429 protein expression level is significantly higher than in the reactive hyperplasias of lymph nodes, and is positively associated with poor overall survival in DLBCL patients [10]. Here, VIRMA is linked to diffuse large B-cell lymphoma.